Phase 3 Trial Finds Experimental Graft-Vs.-Host Disease Treatment Equivalent To Standard Care

Main Category: Immune System / Vaccines Also Included In: Lymphoma / Leukemia / Myeloma ; Stem Cell Research Article Date: 14 Dec 2012 - 0:00 PST An experimental drug combination for preventing graft-versus-host disease was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American ... (more)

http://www.medicalnewstoday.com/releases/253915.php